Pendapatan dodolan perusahaan Cronos Group (CRON)

Cronos Group Inc. (CRON) relies on support from Altria and a unique synthesis of cannabinoids that reduces costs. Efforts to increase profits through premium brands are evident in the company's current sales figures, where the value of 0.21 serves as a baseline metric. However, market oversupply and rising promotion expenses are keeping business margins low.

CRON thecronosgroup.com: Pendapatan perusahaan ing interval 04.07.2022 - 13.11.2026

Rincian analitis perusahaan Cronos Group Inc.

- nilai saham lan prakiraan konsensus rega:

Kutipan saham Cronos Corp|CRON - Bagan rega target

- rincian kapitalisasi pasar:

Nilai pasar Cronos Group Inc.|CRON - Nilai Total Perusahaan

- indikator nilai aset resik miturut neraca:

Nilai Aset Bersih saben Saham Cronos Group|CRON - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Nilai Buku thecronosgroup.com|CRON - Aset Agregat Perusahaan

- data liabilitas lan likuiditas perusahaan:

Utang marang Modal Cronos Group Inc.|CRON - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal Cronos Group Inc|CRON - Gunggung utang perusahaan|Rasio utang marang aset resik Cronos Group Inc.|CRON - Utang jangka dawa perusahaan|Tanggungan jangka cendhak Cronos Group|Rasio jangkoan perantara thecronosgroup.com

- data bathi bisnis lan rasio investasi:

CRON - Bathi resik perusahaan|Bathi resik sing dikarepake Cronos Group Inc.|CRON - Koefisien rega marang bathi|Pangali Forward P/E thecronosgroup.com|CRON - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Cronos Group Inc.|CRON - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Cronos Group|CRON - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan thecronosgroup.com|CRON - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Cronos Group Inc.

- indikator volume dodolan lan pendapatan:

CRON - Pendapatan lan volume dodolan|Volume dodolan mangsa ngarep perusahaan Cronos Corp|CRON - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Cronos Group Inc.

Analisis umum perusahaan:Cronos Corp - CRON

Revenue serves as a key indicator of business scaling for Cronos Group Inc. (CRON) across legal cannabis markets. By analyzing the company's total sales on the GURU.Markets platform, investors can observe actual product sales volumes stripped of market noise. This metric captures daily cash inflows from both medical and recreational clients. The price action reflects real demand for branded products in Canada, Israel, and Germany, while a steadily rising curve confirms the resilience of the business model.

Pesaing wigati

Dodolan perusahaan Indivior Corp (INDV)|Pendapatan perusahaan Collegium Pharmaceutical (COLL)|CGC (canopygrowth.com) - Pendapatan dodolan perusahaan|Pendapatan perusahaan High Tide HITI|Aurora Cannabis, Inc. (ACB) - Total pendapatan perusahaan|ACHV - Pendapatan perusahaan|SKYE (Skye Bioscience Inc.) - Volume dodolan perusahaan|Anebulo Pharmaceuticals (ANEB) - Pendapatan perusahaan|Total pendapatan perusahaan InterCure (INCR)|Pendapatan perusahaan Nutriband Inc|Nasus Pharma, Ltd. (NSRX) - Pendapatan reged perusahaan|Dodolan perusahaan IGC (IGC Pharma, Inc.)|MIRA (mirapharmaceuticals.com) - Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan FLGC (Flora Growth Corp.)|Total volume dodolan perusahaan IM Cannabis Corp|ADIL - Pendapatan perusahaan|Pendapatan dodolan perusahaan ARTL (Artelo Biosciences)|ensysce.com (ENSC) - Pendapatan perusahaan|Total pendapatan perusahaan Titan Pharmaceuticals, Inc. (TTNP)|Dodolan perusahaan GNLN|Pendapatan lan volume dodolan inmedpharma.com|Pendapatan perusahaan Akanda Corp. (AKAN)|ENVB: Pendapatan tahunan perusahaan|Bright Green Corporation - Dodolan perusahaan|Pendapatan dodolan perusahaan HPCO